ASIX
AdvanSix Q3 2026 sales up 15% despite adjusted EPS loss
Advansix reported Q326 sales of $431 million, up 15% year-over-year, while adjusted diluted EPS was negative ($0.24) due to reduced output and higher input costs. The company also secured a $47 million Fields Grant for its ammonia platform.
ASIX
AdvanSix Q2 2026 sales up 3% to $421M
AdvanSix announced Q2 2026 sales of $421 million, up 3% year-over-year, with net income dropping sharply amid lower volume in Plant Nutrients. The company reported adjusted earnings per share of $0.19.
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.